Flemster, I understand your point of view but I believe you're throwing a glass of water in the fire. CSL's vaccine business runs at a loss and makes up less than 5% of their resources (also the Novartis aquisition probably won't be realised for another 2-3 years). Moreover, CSL settled a legal case in 2013 for around 20 million - the share price has since doubled. My point, CSL is like a freight train and with the AU-US dollar still likely to slide to 75 cents (revenues must be getting huge), it wouldn't surprise me if we see triple figures in 2015.
Flemster, I understand your point of view but I believe you're...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$279.58 |
Change
-0.340(0.12%) |
Mkt cap ! $135.1B | |||
| Open | High | Low | Value | Volume |
| $279.97 | $282.07 | $278.94 | $155.1M | 554.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 968 | $279.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $279.58 | 401 | 1 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$279.20 |
Change
-0.340 ( 0.28 %) |
||||
| Open | High | Low | Volume | ||
| $280.00 | $282.05 | $278.95 | 30778 | ||
| Last updated 15.59pm 14/05/2024 ? | |||||
| CSL (ASX) Chart |